Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Tempol |
Synonyms | |
Therapy Description |
Tempol is a heterocyclic nitroxide free radical that induces cellular oxidative stress, and may inhibit the activity of Idh1 and Idh2, induce tumor cell death, and inhibit tumor cell proliferation (PMID: 32366855, PMID: 11033415). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Tempol | MTS-01|MBM-02|Piperidine Nitroxide | Tempol is a heterocyclic nitroxide free radical that induces cellular oxidative stress, and may inhibit the activity of Idh1 and Idh2, induce tumor cell death, and inhibit tumor cell proliferation (PMID: 32366855, PMID: 11033415). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05491928 | Expanded access | Tempol | Treatment of Metastatic Cancer in Terminally Diagnosed Patients | Available | USA | 0 |
NCT04874506 | Phase II | Tempol | MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM) | Unknown status | USA | 0 |
NCT04337099 | Expanded access | Tempol | A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer | Available | USA | 0 |
NCT04876755 | Phase II | Tempol | MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer | Unknown status | USA | 0 |